Stratos Wealth Advisors’s AtriCure ATRC Stock Holding History

Stratos Wealth Advisors’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,472	Closed	-$216K	–	614
2025 Q4	$216K	Buy	+5,472	New	+$201K	0.01%	612

Other funds holding ATRC

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Stratos Wealth Advisors's ATRC Position: Q1 2026 in Review

Stratos Wealth Advisors sold out of AtriCure (ATRC) in Q1 2026, closing a stake of 5,472 shares — an estimated $216K sold.

Stratos Wealth Advisors first reported a position in ATRC in Q4 2025 and held it in 1 quarter. The position peaked at $216K in Q4 2025. 224 funds tracked by Wall St. Rank hold ATRC as of Q1 2026.

Stratos Wealth Advisors reported no remaining AtriCure position as of Q1 2026 after selling out during the quarter.
Stratos Wealth Advisors sold 5,472 AtriCure shares in Q1 2026, an estimated $216K.
Stratos Wealth Advisors first reported a position in AtriCure in Q4 2025 and held it in 1 quarter.
Stratos Wealth Advisors's AtriCure position peaked at $216K in Q4 2025.
224 funds tracked by Wall St. Rank held AtriCure as of Q1 2026.

Based on Stratos Wealth Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.